DCF Advisers
Latest statistics and disclosures from DCF Advisers's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SPY, MU, GOOG, REGN, QQQ, and represent 34.70% of DCF Advisers's stock portfolio.
- Added to shares of these 10 stocks: SPY (+$19M), SPLG, BIDU, GDX, RVNC, TEVA, LFCR, TDOC, PRTA, Coherus Biosciences.
- Started 10 new stock positions in Coherus Biosciences, ESPR, Revance Therapeutics, BIDU, IOT, SPLG, ARQ, PANW, YETI, TDOC.
- Reduced shares in these 10 stocks: QQQ (-$22M), BMY, Seagen, ABBV, REGN, ORCL, GDXJ, T, MU, AMD.
- Sold out of its positions in AIRT, ALNY, AMZN, BMY, EQ, ImmunoGen, IMPLQ, MSFT, RTX, XBI. Seagen, Turning Pt Brands, United States Natural Gas Fund, Lp etf, PARA, VIR.
- DCF Advisers was a net seller of stock by $-16M.
- DCF Advisers has $203M in assets under management (AUM), dropping by 10.60%.
- Central Index Key (CIK): 0001802493
Tip: Access up to 7 years of quarterly data
Positions held by DCF Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for DCF Advisers
DCF Advisers holds 76 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 10.4 | $21M | +710% | 41k | 523.07 |
|
| Micron Technology (MU) | 9.5 | $19M | -5% | 164k | 117.89 |
|
| Alphabet Cap Stk Cl C (GOOG) | 5.4 | $11M | +2% | 72k | 152.26 |
|
| Regeneron Pharmaceuticals (REGN) | 5.0 | $10M | -13% | 11k | 962.49 |
|
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 4.4 | $8.9M | -70% | 20k | 444.01 |
|
| Argenx Se Sponsored Adr (ARGX) | 3.9 | $8.0M | -8% | 20k | 393.72 |
|
| Advanced Micro Devices (AMD) | 3.4 | $6.9M | -13% | 38k | 180.49 |
|
| Intra Cellular Therapies (ITCI) | 3.3 | $6.7M | -9% | 97k | 69.20 |
|
| Abbvie (ABBV) | 2.9 | $5.8M | -28% | 32k | 182.10 |
|
| Spdr Gold Tr Gold Shs (GLD) | 2.7 | $5.6M | -15% | 27k | 205.72 |
|
| Eli Lilly & Co. (LLY) | 2.7 | $5.4M | -6% | 7.0k | 777.96 |
|
| Oracle Corporation (ORCL) | 2.5 | $5.1M | -22% | 41k | 125.61 |
|
| Energy Transfer Com Ut Ltd Ptn (ET) | 2.4 | $4.9M | -17% | 309k | 15.73 |
|
| Bank of America Corporation (BAC) | 2.3 | $4.8M | -3% | 125k | 37.92 |
|
| Xencor (XNCR) | 2.3 | $4.6M | -15% | 209k | 22.13 |
|
| Ishares Gold Tr Ishares New (IAU) | 2.1 | $4.2M | 100k | 42.01 |
|
|
| Spdr Ser Tr Portfolio S&p500 Put Option (SPLG) | 1.9 | $3.8M | NEW | 63k | 61.53 |
|
| Incyte Corporation (INCY) | 1.4 | $2.9M | +15% | 52k | 56.97 |
|
| Amgen (AMGN) | 1.4 | $2.9M | -9% | 10k | 284.32 |
|
| Zimmer Holdings (ZBH) | 1.4 | $2.9M | +18% | 22k | 131.98 |
|
| Alibaba Group Hldg Sponsored Ads (BABA) | 1.4 | $2.8M | -17% | 38k | 72.36 |
|
| Prothena Corp SHS (PRTA) | 1.3 | $2.7M | +28% | 107k | 24.77 |
|
| Apple (AAPL) | 1.2 | $2.5M | -19% | 15k | 171.48 |
|
| Turning Pt Brands (TPB) | 1.2 | $2.4M | 84k | 29.30 |
|
|
| Ishares Tr Russell 2000 Etf (IWM) | 1.2 | $2.4M | 12k | 210.30 |
|
|
| Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal) | 1.1 | $2.3M | -8% | 2.8M | 0.83 |
|
| Nuveen Cr Strategies Income Com Shs (JQC) | 1.1 | $2.3M | 415k | 5.57 |
|
|
| Altimmune Com New (ALT) | 1.1 | $2.2M | 217k | 10.18 |
|
|
| Aberdeen Total Dynamic Divd Com Sh Ben Int (AOD) | 1.1 | $2.2M | +3% | 262k | 8.29 |
|
| Baidu Spon Adr Rep A (BIDU) | 1.1 | $2.1M | NEW | 20k | 105.28 |
|
| General Motors Company (GM) | 0.8 | $1.6M | -20% | 35k | 45.35 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.7 | $1.5M | +141% | 108k | 14.11 |
|
| Landec Corporation (LFCR) | 0.7 | $1.5M | +135% | 285k | 5.31 |
|
| Vaneck Etf Trust Gold Miners Etf (GDX) | 0.7 | $1.5M | +352% | 48k | 31.62 |
|
| Cisco Systems (CSCO) | 0.7 | $1.5M | +33% | 30k | 49.91 |
|
| Qualcomm (QCOM) | 0.7 | $1.4M | -37% | 8.5k | 169.30 |
|
| O-i Glass (OI) | 0.7 | $1.4M | +44% | 86k | 16.59 |
|
| Ford Motor Company (F) | 0.7 | $1.3M | 100k | 13.28 |
|
|
| Revance Therapeutics (RVNC) | 0.6 | $1.3M | +893% | 263k | 4.92 |
|
| Marvell Technology (MRVL) | 0.6 | $1.2M | 18k | 70.88 |
|
|
| Barrick Gold Corp (GOLD) | 0.6 | $1.2M | +38% | 73k | 16.64 |
|
| At&t (T) | 0.6 | $1.1M | -54% | 65k | 17.60 |
|
| Ishares Silver Tr Ishares (SLV) | 0.6 | $1.1M | 50k | 22.75 |
|
|
| Ea Series Trust Alpha Arch 1-3 (BOXX) | 0.5 | $1.1M | +31% | 9.9k | 106.46 |
|
| Meta Platforms Cl A (META) | 0.5 | $971k | 2.0k | 485.58 |
|
|
| Boulder Growth & Income Fund (STEW) | 0.4 | $889k | 59k | 15.06 |
|
|
| Burford Cap Ord Shs (BUR) | 0.4 | $878k | -6% | 55k | 15.97 |
|
| Boeing Company (BA) | 0.4 | $849k | +120% | 4.4k | 192.99 |
|
| Intel Corporation (INTC) | 0.4 | $828k | -39% | 19k | 44.17 |
|
| Lensar (LNSR) | 0.4 | $809k | -15% | 238k | 3.40 |
|
| Teladoc (TDOC) | 0.4 | $776k | NEW | 51k | 15.10 |
|
| Paypal Holdings (PYPL) | 0.4 | $737k | -18% | 11k | 66.99 |
|
| Pan American Silver Corp Can (PAAS) | 0.3 | $679k | 45k | 15.08 |
|
|
| Wolfspeed (WOLF) | 0.3 | $608k | +14% | 21k | 29.50 |
|
| Yeti Hldgs (YETI) | 0.3 | $578k | NEW | 15k | 38.55 |
|
| Coherus Biosciences Note 1.500% 4/1 (Principal) | 0.3 | $578k | NEW | 900k | 0.64 |
|
| Sanofi Sponsored Adr (SNY) | 0.3 | $535k | +11% | 11k | 48.60 |
|
| Pfizer (PFE) | 0.3 | $534k | -50% | 19k | 27.75 |
|
| Vaneck Etf Trust Junior Gold Mine (GDXJ) | 0.3 | $531k | -72% | 14k | 38.74 |
|
| Spotify Technology S A SHS (SPOT) | 0.3 | $528k | 2.0k | 263.90 |
|
|
| Ishares Tr Msci Emg Mkt Etf (EEM) | 0.3 | $514k | 13k | 41.08 |
|
|
| Lam Research Corporation (LRCX) | 0.2 | $486k | 500.00 | 971.57 |
|
|
| Citigroup Com New (C) | 0.2 | $459k | 7.3k | 63.24 |
|
|
| Revance Therapeutics Note 1.750% 2/1 (Principal) | 0.2 | $426k | NEW | 600k | 0.71 |
|
| Samsara Com Cl A (IOT) | 0.2 | $378k | NEW | 10k | 37.79 |
|
| Evotec Sponsored Ads (EVO) | 0.2 | $374k | -2% | 48k | 7.83 |
|
| Palo Alto Networks (PANW) | 0.1 | $284k | NEW | 1.0k | 284.13 |
|
| Miragen Therapeutics (VRDN) | 0.1 | $254k | +7% | 15k | 17.51 |
|
| Johnson & Johnson (JNJ) | 0.1 | $237k | 1.5k | 158.19 |
|
|
| Nokia Corp Sponsored Adr (NOK) | 0.1 | $177k | -70% | 50k | 3.54 |
|
| Lineage Cell Therapeutics In (LCTX) | 0.1 | $160k | +30% | 108k | 1.48 |
|
| Advanced Emissions (ARQ) | 0.1 | $104k | NEW | 16k | 6.48 |
|
| Kirkland's (KIRK) | 0.0 | $61k | -27% | 25k | 2.41 |
|
| Ovid Therapeutics (OVID) | 0.0 | $60k | -35% | 20k | 3.05 |
|
| Amarin Corp Spons Adr New (AMRN) | 0.0 | $12k | -5% | 13k | 0.89 |
|
| Esperion Therapeutics Call Option (ESPR) | 0.0 | $9.4k | NEW | 3.5k | 2.68 |
|
Past Filings by DCF Advisers
SEC 13F filings are viewable for DCF Advisers going back to 2019
- DCF Advisers 2024 Q1 filed May 15, 2024
- DCF Advisers 2023 Q3 filed Nov. 13, 2023
- DCF Advisers 2023 Q2 filed Aug. 9, 2023
- DCF Advisers 2023 Q1 filed May 15, 2023
- DCF Advisers 2022 Q4 filed Feb. 13, 2023
- DCF Advisers 2022 Q3 filed Nov. 14, 2022
- DCF Advisers 2022 Q2 filed Aug. 11, 2022
- DCF Advisers 2022 Q1 filed May 13, 2022
- DCF Advisers 2021 Q4 filed Feb. 10, 2022
- DCF Advisers 2021 Q3 filed Nov. 15, 2021
- DCF Advisers 2021 Q2 filed Aug. 13, 2021
- DCF Advisers 2021 Q1 filed May 12, 2021
- DCF Advisers 2020 Q4 filed Feb. 12, 2021
- DCF Advisers 2020 Q3 filed Nov. 13, 2020
- DCF Advisers 2020 Q2 filed Aug. 13, 2020
- DCF Advisers 2020 Q1 filed May 12, 2020